login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ATAI BECKLEY NV (ATAI) Stock News
USA
- NASDAQ:ATAI -
NL0015000DX5
-
Common Stock
4.43
USD
+0.08 (+1.84%)
Last: 11/11/2025, 6:14:01 PM
4.52
USD
+0.09 (+2.03%)
After Hours:
11/11/2025, 6:14:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ATAI Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: AtaiBeckley N.V.
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
6 days ago - By: AtaiBeckley N.V.
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
6 days ago - By: AtaiBeckley N.V.
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
20 days ago - By: Benzinga
Analyst Expectations For ATAI Life Sciences's Future
2 months ago - By: Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
22 days ago - By: atai Life Sciences
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
22 days ago - By: atai Life Sciences
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
22 days ago - By: Zacks Investment Research
atai Life Sciences (ATAI) Upgraded to Buy: Here's Why
25 days ago - By: The Motley Fool
Why Atai Life Sciences Stock Was So Lively This Week
26 days ago - By: atai Life Sciences
atai Life Sciences Announces Pricing of Public Offering of Common Shares
26 days ago - By: atai Life Sciences
atai Life Sciences Announces Pricing of Public Offering of Common Shares
a month ago - By: atai Life Sciences
atai Life Sciences Announces Proposed Public Offering of Common Shares
a month ago - By: atai Life Sciences
atai Life Sciences Announces Proposed Public Offering of Common Shares
a month ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
a month ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
2 months ago - By: The Motley Fool
Why Atai Life Sciences Stock Crushed It on Tuesday
2 months ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
2 months ago - By: atai Life Sciences
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
2 months ago - By: atai Life Sciences
atai Life Sciences Awarded Grant from the National Institutes of Health
2 months ago - By: atai Life Sciences
atai Life Sciences Awarded Grant from the National Institutes of Health
2 months ago - By: Zacks Investment Research
- Mentions:
HALO
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?
3 months ago - By: atai Life Sciences
atai Life Sciences to Participate in September Investor Conferences
3 months ago - By: atai Life Sciences
atai Life Sciences to Participate in September Investor Conferences
3 months ago - By: Zacks Investment Research
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now
3 months ago - By: atai Life Sciences
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
3 months ago - By: atai Life Sciences
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
3 months ago - By: Yahoo Finance
H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10
Please enable JavaScript to continue using this application.